Translational Research
Volume 152, Issue 2 , Pages 88-94, August 2008

Responses to tiotropium in African-American and Caucasian patients with chronic obstructive pulmonary disease

Veterans Affairs Medical Center, Minneapolis, Minn, and Boehringer-Ingelheim Pharmaceuticals, Ridgefield, Conn.

Received 11 March 2008; received in revised form 15 May 2008; accepted 30 May 2008. published online 24 June 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by honoraria, consultancies, and employment from Boehringer Ingelheim Pharmaceuticals and Pfizer, Inc. (to all authors) and from AstraZeneca, Aventis, Sanofi Pasteur, and GlaxoSmithKline (to D.E.N.). Supported also by grants from Boehringer Ingelheim Pharmaceuticals, Aventis, and Sanofi Pasteur (to K.R.) as well as from Boehringer Ingelheim Pharmaceuticals and GlaxoSmithKline (to D.E.N.).

PII: S1931-5244(08)00155-2

doi:10.1016/j.trsl.2008.05.011

Translational Research
Volume 152, Issue 2 , Pages 88-94, August 2008

Article Tools

* Image Usage & Resolution